AI Article Synopsis

  • Exogenous supplementation of guanidinoacetic acid (GAA) was studied in ducks to see its effects on fat deposition, lipid levels, and gene expression related to lipid metabolism.
  • Ducks were divided into four groups: a control group with a regular diet and three experimental groups receiving different doses of GAA (400, 600, and 800 mg/kg).
  • Results showed that GAA significantly reduced cholesterol and triglyceride levels in both liver and breast muscle, with the most effective dose being 600 mg/kg, which also enhanced specific lipid metabolism-related gene expressions.

Article Abstract

Exogenous supplementation of guanidinoacetic acid can mechanistically regulate the energy distribution in muscle cells. This study aimed to investigate the effects of guanidinoacetic acid supplementation on liver and breast muscle fat deposition, lipid levels, and lipid metabolism-related gene expression in ducks. We randomly divided 480 42 days-old female Jiaji ducks into four groups with six replicates and 20 ducks for each replicate. The control group was fed the basal diet, and the experimental groups were fed the basal diet with 400, 600, and 800 mg/kg (GA400, GA600, and GA800) guanidinoacetic acid, respectively. Compared with the control group, (1) the total cholesterol ( = 0.0262), triglycerides ( = 0.0357), malondialdehyde ( = 0.0452) contents were lower in GA400, GA600 and GA800 in the liver; (2) the total cholesterol ( = 0.0365), triglycerides ( = 0.0459), and malondialdehyde ( = 0.0326) contents in breast muscle were decreased in GA400, GA600 and GA800; (3) the high density lipoprotein ( = 0.0356) and apolipoprotein-A1 ( = 0.0125) contents were increased in GA600 in the liver; (4) the apolipoprotein-A1 contents ( = 0.0489) in breast muscle were higher in GA600 and GA800; (5) the lipoprotein lipase contents ( = 0.0325) in the liver were higher in GA600 and GA800; (6) the malate dehydrogenase contents ( = 0.0269) in breast muscle were lower in GA400, GA600, and GA800; (7) the ( = 0.0326), ( = 0.0412), and ( = 0.0235) relative expression were higher in GA400, GA600, and GA800 in the liver; (8) the ( = 0.0269), ( = 0.0234), and ( = 0.0425) relative expression were increased in GA400, GA600, and GA800 in breast muscle. In this study, the optimum dosage of 600 mg/kg guanidinoacetic acid improved the liver and breast muscle fat deposition, lipid levels, and lipid metabolism-related gene expression in ducks.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10904544PMC
http://dx.doi.org/10.3389/fvets.2024.1364815DOI Listing

Publication Analysis

Top Keywords

ga600 ga800
32
breast muscle
28
ga400 ga600
24
guanidinoacetic acid
20
liver breast
12
muscle fat
12
fat deposition
12
deposition lipid
12
lipid levels
12
levels lipid
12

Similar Publications

Article Synopsis
  • Exogenous supplementation of guanidinoacetic acid (GAA) was studied in ducks to see its effects on fat deposition, lipid levels, and gene expression related to lipid metabolism.
  • Ducks were divided into four groups: a control group with a regular diet and three experimental groups receiving different doses of GAA (400, 600, and 800 mg/kg).
  • Results showed that GAA significantly reduced cholesterol and triglyceride levels in both liver and breast muscle, with the most effective dose being 600 mg/kg, which also enhanced specific lipid metabolism-related gene expressions.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!